We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 32.58%
This Fund
S&P 500
This Quarter Est. Return
+5.08%
1 Year Est. Return
+32.58%
3 Year Est. Return
+102.78%
5 Year Est. Return
+138.55%
10 Year Est. Return
+393.68%
AUM
$1.01B
AUM Growth
-$138M
Cap. Flow
-$23.3M
Cap. Flow %
-2.32%
Top 10 Hldgs %
26.38%
Holding
127
New
17
Increased
17
Reduced
26
Closed
9

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$19.7M
2
GILD icon
Gilead Sciences
GILD
+$19.1M
3
LLY icon
Eli Lilly
LLY
+$16.1M
4
SO icon
Southern Company
SO
+$15.7M
5
HD icon
Home Depot
HD
+$15.2M

Top Sells

Rank Stock Value
1
RAI
Reynolds American Inc
RAI
+$26.3M
2
JNJ icon
Johnson & Johnson
JNJ
+$20.3M
3
CME icon
CME Group
CME
+$18M
4
IBM icon
IBM
IBM
+$17.9M
5
KO icon
Coca-Cola
KO
+$14.3M

Sector Composition

Rank Sector Weight
1 Financials 15.74%
2 Technology 14.54%
3 Energy 11.27%
4 Healthcare 10.79%
5 Consumer Staples 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
76
Johnson & Johnson
JNJ
$645B
$1.33M 0.13%
10,200
-153,500
-94% -$20.3M
MMP
77
DELISTED
Magellan Midstream Partners, L.P.
MMP
$1.3M 0.13%
18,300
– –
SPG icon
78
Simon Property Group
SPG
$66.8B
$493K 0.05%
3,060
– –
SPY icon
79
State Street SPDR S&P 500 ETF Trust
SPY
$805B
$468K 0.05%
1,863
-107
-5% -$26.4K
MCHP icon
80
Microchip Technology
MCHP
$39.7B
$458K 0.05%
10,200
-340,400
-97% -$14.3M
WMT icon
81
Walmart Inc
WMT
$841B
$330K 0.03%
12,660
-411,900
-97% -$10.8M
AEE icon
82
Ameren
AEE
$29.3B
$301K 0.03%
5,200
– –
BRK.A icon
83
Berkshire Hathaway Class A
BRK.A
$1.09T
$275K 0.03%
1
– –
IGIB icon
84
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$247K 0.02%
4,500
– –
AAPL icon
85
Apple
AAPL
$4.58T
$216K 0.02%
5,600
– –
HEFA icon
86
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.43B
$191K 0.02%
6,600
– –
COF icon
87
Capital One
COF
$130B
$167K 0.02%
1,969
– –
PEP icon
88
PepsiCo
PEP
$187B
$167K 0.02%
1,500
– –
DVY icon
89
iShares Select Dividend ETF
DVY
$23.5B
$140K 0.01%
1,500
– –
TMO icon
90
Thermo Fisher Scientific
TMO
$224B
$132K 0.01%
700
– –
IWF icon
91
iShares Russell 1000 Growth ETF
IWF
$125B
$125K 0.01%
4,000
– –
ECL icon
92
Ecolab
ECL
$76.8B
$116K 0.01%
900
– –
SCHW
93
Charles Schwab
SCHW
$186B
$115K 0.01%
2,633
– –
NKE icon
94
Nike
NKE
$55B
$104K 0.01%
2,000
– –
GOOGL icon
95
Alphabet (Google) Class A
GOOGL
$4.03T
$97K 0.01%
2,000
– –
GOOG icon
96
Alphabet (Google) Class C
GOOG
$4T
$96K 0.01%
2,000
– –
BRK.B icon
97
Berkshire Hathaway Class B
BRK.B
$1.09T
$91K 0.01%
496
– –
SRCL
98
DELISTED
Stericycle Inc
SRCL
$86K 0.01%
1,200
– –
CSX icon
99
CSX Corp
CSX
$89.6B
$81K 0.01%
4,500
– –
NVS icon
100
Novartis
NVS
$261B
$75K 0.01%
978
– –
2 3
4
5 6

Similar funds

TA
TCM Advisors Martinsburg, West Virginia $1.3B AUM 19.21% 1-Year Est. Return
SI
Sora Investors Bryn Mawr, Pennsylvania $1.3B AUM 77.75% 1-Year Est. Return
GH
GAM Holding Zurich, Switzerland $1.31B AUM 35.17% 1-Year Est. Return
SW
SlateStone Wealth Jupiter, Florida $1.31B AUM 26.51% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
BI
Bramshill Investments Naples, Florida $1.31B AUM 1.2% 1-Year Est. Return
FFL
Flat Footed LLC Wilson, Wyoming $1.31B AUM 86.49% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.3B AUM 18.84% 1-Year Est. Return

Payden & Rygel's Q3 2017 Portfolio in Review

As of Q3 2017, Payden & Rygel held 127 positions worth $1.01B, down 12% from $1.14B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Payden & Rygel's Q3 2017 filing shows 17 new, 17 increased, 26 reduced and 9 closed positions. Its largest new stake was Texas Instruments: 239,900 shares worth $21.5M. The largest sale was Reynolds American Inc, an estimated $26.3M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 10% a quarter earlier, followed by Technology and Energy.

  • Payden & Rygel's largest Q3 2017 buy was Texas Instruments: 239,900 shares worth $21.5M.
  • Payden & Rygel added most to Gilead Sciences in Q3 2017, an estimated $19.1M increase.
  • Payden & Rygel's biggest Q3 2017 reduction was Johnson & Johnson, cutting an estimated $20.3M.
  • Payden & Rygel fully exited Reynolds American Inc in Q3 2017, selling an estimated $26.3M.
  • Payden & Rygel's ten largest holdings make up 26% of its $1.01B portfolio in Q3 2017.
  • Payden & Rygel opened 17 new positions and closed 9 in Q3 2017.
  • Payden & Rygel's portfolio value fell 12% quarter-over-quarter to $1.01B.

Based on Payden & Rygel's 13F filing for Q3 2017, filed 14 Nov 2017.